Givaudan reports strong Q1 FY25 financial results
The company reported solid growth across its business segments.
SWITZERLAND – Givuadan, a Swiss manufacturer of fragrances and active cosmetic ingredients, recorded sales of CHF 1,977 million(USD 2,425 million) in the first three months of 2025.
This reflects an increase of 7.4% on a like-for-like (LFL) basis1 and an increase of 8.5% in Swiss francs.
According to the company, they began the year with strong momentum, achieving solid growth across its business segments and markets while keeping its operations and global supply chain running efficiently.
Gilles Andrier, CEO at Givuadan, stated, “We are very pleased with the strong start to the year across business segments, customer groups, and geographies, against very strong prior-year comparables.”
“With ongoing uncertainty in relation to global trade tariffs, we remain focused on our strategy and on delivering innovative solutions to help drive the growth of our customers.”
In high-growth markets, sales increased by 12.8% on an LFL basis, following a 21.8% growth in the previous year.
Sales in mature markets grew by 2.6% on a like-for-like basis, compared to a 5.5% increase recorded in the first quarter of 2024.
Fragrance & Beauty sales reached CHF 1,009 million(USD 1,238 million), marking a 9.8% increase on a like-for-like basis and a 12.2% rise in Swiss francs.
Fine Fragrance sales rose by 16.7% on a LFL basis.
Consumer Products sales saw a 7.9% increase on a like-for-like basis, following a robust 17.6% growth in the prior year.
Fragrance Ingredients and Active Beauty sales grew by 7.7% on a like-for-like basis, following a 10.0% increase in the same period last year.
Sales growth was seen across all regions, with Europe rising 7.1% and South Asia, Africa, and the Middle East achieving a 10.4% increase, building on strong prior-year results.
North America reported a 0.5% sales growth, while Latin America and Asia Pacific showed increases of 5.1% and 6.1%, respectively.
Recently, Givaudan launched a new skincare ingredient, PrimalHyal UltraReverse.
This product is the smallest and most sustainable hyaluronic acid ever developed, with an ultra-low molecular weight of less than 3 kDa.
It is designed to penetrate skin cells and act at the DNA level, addressing key hallmarks of aging such as genomic instability, epigenetic control, telomere attrition, and loss of proteostasis.
PrimalHyal™ UltraReverse targets these biological pathways to help protect the skin from chronological aging and environmental stressors, known as the exposome.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
